A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...

Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 ...

According to the analysis, people who used GLP-1 medications had a 16 percent lower risk of developing epilepsy than those who received DPP-4 inhibitors. The substance semaglutide stood out in ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

The UC Davis Innovation Institute for Food and Health recently hosted scientists, physicians and industry experts to discuss how drugs based on GLP-1 are transforming treatment for obesity, diabetes ...

In the first quarter of 2018, there were less than five postpartum GLP-1 prescriptions, but by the second quarter of 2022, the number rose to 34 per 10,000 and sharply increased to 173 per 10,000 in ...

How to find out if weight loss drugs are covered by your insurance, and what to do if they’re not Ozempic (semaglutide), Victoza (liraglutide), and Wegovy (semaglutide) are popular medications used to ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options ...

Uncover common misconceptions about GLP-1s for weight loss. Learn the importance of diet, exercise, managing side effects, ...

The study thus suggests yet another unexpected avenue for the GLP-1 drugs.